We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck and Glenmark Face Class Action Over Zetia Monopoly Claims
Merck and Glenmark Face Class Action Over Zetia Monopoly Claims
Merck and Glenmark engaged in anticompetitive behavior by keeping a generic version of Zetia off the market, creating a monopoly and manipulating the drug price, according to a newly filed lawsuit seeking class action status in a Virginia federal court.